Therapeutic applications of nanobots and nanocarriers in cancer treatment

<p dir="ltr">Cancer remains a pressing global health concern, burdening individuals, families, and healthcare systems worldwide, mainly because of the limited availability of therapeutic options. These days, nanotechnology is revolutionizing cancer research by offering promising drug...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Zaitoon Khan (22504295) (author)
مؤلفون آخرون: Nimra Khan (19259947) (author), Mithra Geetha (14151807) (author), Reyhanath Pilakka Veettil (22504298) (author), Deepak Mahadev Kasote (22504301) (author), Anwarul Hasan (1332066) (author), Kishor Kumar Sadasivuni (8036039) (author)
منشور في: 2025
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513533553672192
author Zaitoon Khan (22504295)
author2 Nimra Khan (19259947)
Mithra Geetha (14151807)
Reyhanath Pilakka Veettil (22504298)
Deepak Mahadev Kasote (22504301)
Anwarul Hasan (1332066)
Kishor Kumar Sadasivuni (8036039)
author2_role author
author
author
author
author
author
author_facet Zaitoon Khan (22504295)
Nimra Khan (19259947)
Mithra Geetha (14151807)
Reyhanath Pilakka Veettil (22504298)
Deepak Mahadev Kasote (22504301)
Anwarul Hasan (1332066)
Kishor Kumar Sadasivuni (8036039)
author_role author
dc.creator.none.fl_str_mv Zaitoon Khan (22504295)
Nimra Khan (19259947)
Mithra Geetha (14151807)
Reyhanath Pilakka Veettil (22504298)
Deepak Mahadev Kasote (22504301)
Anwarul Hasan (1332066)
Kishor Kumar Sadasivuni (8036039)
dc.date.none.fl_str_mv 2025-06-04T03:00:00Z
dc.identifier.none.fl_str_mv 10.1007/s44211-025-00799-5
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Therapeutic_applications_of_nanobots_and_nanocarriers_in_cancer_treatment/30455939
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Oncology and carcinogenesis
Engineering
Biomedical engineering
Nanotechnology
Cancer treatment
Nanobots
Nanocarriers
Nano-formulation
Drug delivery
dc.title.none.fl_str_mv Therapeutic applications of nanobots and nanocarriers in cancer treatment
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Cancer remains a pressing global health concern, burdening individuals, families, and healthcare systems worldwide, mainly because of the limited availability of therapeutic options. These days, nanotechnology is revolutionizing cancer research by offering promising drug delivery systems. Among these, nanobots and nanocarriers are key nanotechnology components, offering groundbreaking strategies in cancer therapy by delivering drugs, enhancing diagnostics, and preventing diseases at molecular levels. Nanobots and nanocarriers, engineered at sizes ranging from 1 to 100 nm, demonstrate biocompatibility with cellular systems, offer precise drug delivery, and reduce side effects compared to conventional therapies such as chemotherapy and surgery. Research efforts now focus on transitioning nanobots and nanocarriers from laboratories to clinics, aiming for precision medicine, targeted drug delivery, enhanced therapy efficacy, and minimal side effects. This review aims to highlight the potential of nanobots and nanocarriers in cancer treatment and provide insights into their role in paving the way for clinical applications and improving outcomes in cancer therapy.</p><h2>Other Information</h2><p dir="ltr">Published in: Analytical Sciences<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s44211-025-00799-5" target="_blank">https://dx.doi.org/10.1007/s44211-025-00799-5</a></p>
eu_rights_str_mv openAccess
id Manara2_5a1d002f6fdeefd53052be7321041ba5
identifier_str_mv 10.1007/s44211-025-00799-5
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/30455939
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Therapeutic applications of nanobots and nanocarriers in cancer treatmentZaitoon Khan (22504295)Nimra Khan (19259947)Mithra Geetha (14151807)Reyhanath Pilakka Veettil (22504298)Deepak Mahadev Kasote (22504301)Anwarul Hasan (1332066)Kishor Kumar Sadasivuni (8036039)Biomedical and clinical sciencesOncology and carcinogenesisEngineeringBiomedical engineeringNanotechnologyCancer treatmentNanobotsNanocarriersNano-formulationDrug delivery<p dir="ltr">Cancer remains a pressing global health concern, burdening individuals, families, and healthcare systems worldwide, mainly because of the limited availability of therapeutic options. These days, nanotechnology is revolutionizing cancer research by offering promising drug delivery systems. Among these, nanobots and nanocarriers are key nanotechnology components, offering groundbreaking strategies in cancer therapy by delivering drugs, enhancing diagnostics, and preventing diseases at molecular levels. Nanobots and nanocarriers, engineered at sizes ranging from 1 to 100 nm, demonstrate biocompatibility with cellular systems, offer precise drug delivery, and reduce side effects compared to conventional therapies such as chemotherapy and surgery. Research efforts now focus on transitioning nanobots and nanocarriers from laboratories to clinics, aiming for precision medicine, targeted drug delivery, enhanced therapy efficacy, and minimal side effects. This review aims to highlight the potential of nanobots and nanocarriers in cancer treatment and provide insights into their role in paving the way for clinical applications and improving outcomes in cancer therapy.</p><h2>Other Information</h2><p dir="ltr">Published in: Analytical Sciences<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s44211-025-00799-5" target="_blank">https://dx.doi.org/10.1007/s44211-025-00799-5</a></p>2025-06-04T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s44211-025-00799-5https://figshare.com/articles/journal_contribution/Therapeutic_applications_of_nanobots_and_nanocarriers_in_cancer_treatment/30455939CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/304559392025-06-04T03:00:00Z
spellingShingle Therapeutic applications of nanobots and nanocarriers in cancer treatment
Zaitoon Khan (22504295)
Biomedical and clinical sciences
Oncology and carcinogenesis
Engineering
Biomedical engineering
Nanotechnology
Cancer treatment
Nanobots
Nanocarriers
Nano-formulation
Drug delivery
status_str publishedVersion
title Therapeutic applications of nanobots and nanocarriers in cancer treatment
title_full Therapeutic applications of nanobots and nanocarriers in cancer treatment
title_fullStr Therapeutic applications of nanobots and nanocarriers in cancer treatment
title_full_unstemmed Therapeutic applications of nanobots and nanocarriers in cancer treatment
title_short Therapeutic applications of nanobots and nanocarriers in cancer treatment
title_sort Therapeutic applications of nanobots and nanocarriers in cancer treatment
topic Biomedical and clinical sciences
Oncology and carcinogenesis
Engineering
Biomedical engineering
Nanotechnology
Cancer treatment
Nanobots
Nanocarriers
Nano-formulation
Drug delivery